Pay in 4 interest-free payments of $7.45 Learn more
Ships within 48 hours · Estimated delivery Aug 27 - Sep 1
The study found the GLP-1 group had significantly better survival and lower risk of AFib when compared to matched patients in the control group
& Na, D
Additional data were gathered on covariate adjustment strategies (e.g., age, sex, and metabolic disorders) and relevant medical histories (e.g., obesity, type 2 diabetes mellitus)
A 2018 study in Nature Biotechnology documented tertiary patenting on drug-device combinations patents filed on the device after the product had already been on the market for years, often covering minor mechanical refinements or ergonomic changes with no clinical data supporting improved outcomes
US$ 21.02
US$ 21.51
US$ 21.86
US$ 23.85
US$ 25.62
US$ 24.54
US$ 29.84
US$ 25.80
US$ 22.62
